DGAP-News: MeVis Medical Solutions AG: MeVis' profitability further increased in 2012
(firmenpresse) - DGAP-News: MeVis Medical Solutions AG / Key word(s): Final Results
MeVis Medical Solutions AG: MeVis' profitability further increased in
2012
26.04.2013 / 07:30
---------------------------------------------------------------------
MeVis Medical Solutions sees slight fall in sales, substantial reduction in
costs, and significant earnings improvements
- Consolidated sales declined slightly by 2 % to EUR 13.3 m (previous
year: EUR 13.7 m)
- Maintenance business further grew by 8 % to EUR 6.0 m (previous year:
EUR 5.5 m); new licensing business fell by 8 % to EUR 7.0 m (previous
year: EUR 7.6 m)
- EBIT of EUR 3.0 m (22 % margin), significantly above previous year (EUR
1.2 m before extraordinary items)
- Consolidated net profit of EUR 2.2 m (previous year: EUR -4.1 m)
- Stable cash flow from operating activities of EUR 5.3 m (previous year:
EUR 5.1 m)
- Liquidity increased by EUR 1.2 m to EUR 8.7 m despite purchase price
payment of EUR 1.4 m
Bremen, April 26, 2013 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a
leading software provider for the medical imaging market, has released the
final results for its 2012 fiscal year. Earnings and liquidity could be
increased significantly despite a slight decline in sales.
2012 group revenues fell by 2 % to EUR 13.3 m. While sales of new licenses
declined by 8 %, revenues from maintenance contracts continued to do well
and grew throughout the Group by 8 %, now representing 45 % of total net
sales (previous year: 41 %).
Reporting a 3 % decline in segment sales to EUR 10.1 m, the Digital
Mammography segment was once again the top performer in the Group over the
last fiscal year. The segment's net profit amounted to EUR 5.2 m (previous
year: EUR 5.6 m).
Net sales in the Other Diagnostics segment grew slightly to EUR 3.2 m.
Maintenance revenues have substantially increased in this segment as well:
Standing at EUR 0.9 m, they now account for 29 % of the segment's total
sales (previous year: 24 %).
Costs have been substantially reduced again in 2012: Personnel costs
declined by EUR 1.1 m to EUR 8.1 m and other operating expenses by EUR 0.7
m to EUR 2.3 m.
Depreciation and amortization decreased to EUR 3.0 m (previous year: EUR
6.1 m, including a one-off impairment loss of EUR 2.5 m).
Due to the cost reduction measures, earnings before interest and taxes
(EBIT) increased to EUR 3.0 m (previous year: EUR 1.2 m before
extraordinary items) thereby reaching an EBIT margin of 22 %.
The Group financial result improved from EUR -1.3 m to EUR -0.6 m, based on
earnings improvements of the Dutch company Medis where we hold a 41 %
stake.
After tax expenses of EUR 0.2 m (previous year: EUR 1.2 m), the
consolidated net result for the period came to EUR 2.0 m (previous year:
EUR -4.1 m) which corresponds to earnings per share of EUR 1.26 (previous
year: EUR -2.38).
During the fiscal year 2012, liquidity increased by EUR 1.2 m to EUR 8.7 m.
In addition, a last purchase price payment of EUR 1.4 m was paid out of the
operating cash flow, thus in total EUR 2.6 m liquidity could be generated
in 2012.
The equity ratio increased from 64 % to 74 %.
Dr. Robert Hannemann, CFO at MeVis Medical Solutions AG, said, 'Based on
the development of our new license business, we expect another slight
revenue decline in the current fiscal year. By expanding our conservative
approach to capitalization of development expenses, we will minimize
balance sheet risks but also impact current year's EBIT. As a result, we
expect a slight EBIT decline this year.'
Marcus Kirchhoff, Chairman of the Executive Board and CEO of MeVis Medical
Solutions AG, added: 'In order to increase revenues in the years to come,
we intend to broaden our relationships with existing customers, to acquire
new industrial customers, and to establish new sales channels. The
successful execution of the group consolidation brought us into a liquidity
and cost position which provides us with sufficient financial leeway to
pursue interesting growth opportunities.'
Due to the current developments and market conditions, the Executive Board
will provide further details about its business forecast during the course
of the current fiscal year.
The financial reports of the company can be downloaded at
http://www.mevis.de/ir_finanzberichte.html.
End of Corporate News
---------------------------------------------------------------------
26.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir(at)mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
208643 26.04.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.04.2013 - 07:30 Uhr
Sprache: Deutsch
News-ID 253225
Anzahl Zeichen: 7223
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 275 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MeVis Medical Solutions AG: MeVis' profitability further increased in 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
MeVis Medical Solutions AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
